Table 1 Table of individual patients showing the mutation location, cDNA and protein consequences, and variant allele frequencies (VAF)

From: Somatic activating mutations in MAP2K1 cause melorheostosis

Subject

AA Changes

VAF WES affected bone

VAF WES unaffected bone

VAF amplicon affected bone

VAF ddPCR affected bone

VAF ddPCR unaffected bone

VAF ddPCR skin

VAF ddPCR unaffected skin

VAF ddPCR blood

melo4

NM_002755:exon2:c.A167C:p.Q56P

10.1%a

0.00%

N.D.

9.4%

0.0%

12.5%

0.0%

0.0%

melo9

NM_002755:exon2:c.A167C:p.Q56P

17.19%a

0.00%

N.D.

20.0%

0.0%

N.D.

N.D.

0.0%

melo19

NM_002755:exon2:c.A167C:p.Q56P

30.86%a

0.99%

27.9%

27.8%

0.0%

N.D.

N.D.

N.D.

melo10

NM_002755:exon2:c.A169G:p.K57E

12.07%a

0.00%

16.7%

18.3%

0.0%

N.D.

N.D.

0.0%

melo2

NM_002755:exon2:c.G171T:p.K57N

6.09%

0.00%

7.2%

7.0%

0.0%

4.1%

0.0%

0.0%

melo6

NM_002755:exon2:c.G171T:p.K57N

3.12%

0.00%

4.8%

4.4%

0.0%

16.2%

0.0%

0.0%

melo16

NM_002755:exon2:c.G171T:p.K57N

1.04%

0.00%

2.7%

2.8%

0.0%

0.0%

0.0%

0.0%

melo18

NM_002755:exon2:c.G171T:p.K57N

25.21%a

0.0%

34.4%

33.6%

0.0%

6.5%

N.D.

0.0%

  1. a Cases where MAP2K1 mutations were identified through automated filtering of WES for somatic mutations. Others were found by manual inspection. Mutations were not identified in normal control bone. Melo-19 had one mutant read in unaffected bone that was not seen in ddPCR, designating it as a sequencing error. The VAF results from ddPCR, amplicon and whole exome sequencing are highly correlated (R = 0.96 or greater for all comparisons, p < 0.003). MAP2K1 mutations are present in overlying skin in four of five patients tested while contralateral skin is negative. N.D. not done